Good article published today that goes into USC acquisition
They did not do their homework on SLXP. SLXP was quite shadowy re: inventories - worth nowhere near what they paid. Tough ride going forward, IMO.
Try calling investor relations. Plenty going on with the inhalers
Sentiment: Strong Buy
See sec filings on edgar